-
[show abstract]
[hide abstract]
ABSTRACT: Protective and curative effects of the ginkgo biloba extract are known for a long time and confirmed the practical reality. Its main benefit is due to its antioxidant properties, manifested by activation of free radicals by flavonoids contained in gingko by binding free radicals.
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(1):27-9.
-
[show abstract]
[hide abstract]
ABSTRACT: The purpose of glaucoma treatment is to prevent progressive loss of optic nerve fibers and thereby to preserve the visual field. Because increased IOP is a primary risk factor in developing glaucoma, descrease its value below which may affect the optic is the antiglaucoma treatment target. This paper provides an overview of glaucoma treatment and the use of fixed combinations of topical prostaglandin analogues (PGA).
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(3):82-8.
-
[show abstract]
[hide abstract]
ABSTRACT: Anti-inflamatory medication is commonly used to reduce inflammation, edema and symptoms associated with allergies, trauma and infections diseases. Topical nonsteroidial anti-inflammatory (NSAIDs) and topical corticosteroids are overview of the role of topical NSAIDs and the progress of their use in eye surgery
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(3):89-93.
-
[show abstract]
[hide abstract]
ABSTRACT: Topical eye-drops remain the cornerstone of treatment for ocular diseases, including glaucoma. Preservatives are added to multi-dose medication bottles to reduce the risk of microbial contamination, to extend the validity of the product and to allow an easily use of the bottles. However the repetitious use of ophthalmic medications containing preservatives, particularly when treating chronic diseases, has been linked to adverse effects and ocular surface disease (OSD). Therefore, this presentation provides an overview of glaucoma and OSD, the role of preservatives in ophthalmic preparations, and the impact of preservatives on the ocular surface.
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(1):30-3.
-
[show abstract]
[hide abstract]
ABSTRACT: Adjustment of the ocular flow has clear implications in glaucomatous pathology. It cannot be drawn a clear barrier between causality and effect of ocular vascular factor in glaucoma but altered hemodynamics leads clearly to node loss. Unstable ocular perfusion creates a low blood flow to the optic nerve directly involved in glaucomatous optic neuropathy , ocular perfusion pressure (PPO) being a risk factor predictor of progression associated with impairment of visual function in glaucoma.
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(1):34-7.
-
[show abstract]
[hide abstract]
ABSTRACT: Tear film maintain ocular surface health and functional through nutritional support, anti-bacterial properties, viscoelastic protection, smooth optical surface and increase of lubrication. The ocular surface may be affected after surgery (cataract, glaucoma, refractive surgery) or chronic glaucoma treatment.
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(1):38-40.
-
[show abstract]
[hide abstract]
ABSTRACT: Ophthalmic solutions are the main therapeutic methods used in the treatment of ocular diseases, including glaucoma. Preservatives are added in multidose solutions to reduce the risk of microbial contamination. Repeated use of topical medication, especially in patients treated for glaucoma, has many adverse effects especially on the ocular surface. This paper provides an overview of the role of preservatives in antiglaucoma preparations, and their impact on the ocular surface.
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(2):3-6.
-
[show abstract]
[hide abstract]
ABSTRACT: Glaucoma is a medical condition that affects the optic nerve of the eye and can lead to a permanent loss of vision if left untreated. It is now clear that IOP (intraocular pression) lowering treatment may significantly delay or prevent glaucoma development and progression. Although current ocular hypotensive therapy is generally considered safe, alternative treatments may also be considered to slow the progression and prevent the development of complications of the disease.
Oftalmologia (Bucharest, Romania: 1990) 01/2011; 55(2):7-11.
-
[show abstract]
[hide abstract]
ABSTRACT: The authors present a clinical, observational, retrospective, randomized study, performed between 06.01-01.05.2010, on 84 eyes. We have followed the changes of corneal endothelial cell density in patients with primary hypertensional open angle glaucoma, treated using the same therapeutic method, with compensated, undercompensated and decompensated IOP.
Oftalmologia (Bucharest, Romania: 1990) 01/2010; 54(4):115-9.
-
[show abstract]
[hide abstract]
ABSTRACT: To evaluate the results of AcrySof Toric intraocular lens (Alcon) implantation to correct pre-existing astigmatism and rotational stability in patients having cataract surgery or not.
Retrospective study three surgical teams, between February 2009-August 2010, included 37 eyes with more than 1 diopter (D) of preexisting corneal astigmatism having or not cataract surgery.
Rotation at 6 M post-op: 32 patients (87%)--> rotation between aprox. 0-5 degrees, 4 patients (11%)--> rotation between A 5-10 degrees, 1 patient (2%) rotation of A 20 degrees. The mean refractive cylinder decreased significantly after surgery: 34 (91.90%) of cases between 0.25-0.75 D--2 (5.40%) of cases 1.5 D--1 (2.70%) of cases > 1.5 D.
In conclusion the results indicate that TheAcrySof Toric IOL is a viable option of preoperative corneal astigmatism in carefully selected cases. The Toric IOL showed good rotational stability The most frequent cause of turnover is the: viscoelastic left in the capsular bag (early rotation); fibrosis of the bag (late rotation).
Oftalmologia (Bucharest, Romania: 1990) 01/2010; 54(4):120-3.
